Join Alira Health at BPI West this spring in San Diego, CA. Tune in for Bill Perry’s presentation: ‘From Gene to IND – Selecting a CDMO Tailored to mAbs or More…
The COVID-19 pandemic has put unusual pressures on the supply and demand of raw materials required for the production and purification of biologics. A specific concern for the biomanufacturing industry…
Congratulations to Alira Health’s Steven Chamow, Senior Vice President, CMC and founder of Chamow & Associates, and to Bryan Monroe and Chuck Olson, Senior Consultants, on their contributions to “Generation of recombinant hyperimmune globulins from…
Join Steven Chamow, Senior Vice President, CMC, Alira Health, at Bioprocess International US West on March 29-31, 2021. Connect with Steve to discuss how Alira Health can help to facilitate the…
Forbes has named Alira Health one of America’s Best Management Consulting Firms in the healthcare and life sciences space. Chamow & Associates is proud to be a part of the Alira…
In this piece, Nicolas Gaspar, Ph.D., Senior Consultant, Bioassay Development and Quality Control, offers insights for working with a CDMO by digging into the importance of potency as a quality…
A key structural feature of antibody therapeutics is their ability to both bind to antigen and to recruit effector functions of the immune system such as antibody dependent cell mediated…
In this Digital Brief recording, Alira Health’s Steven Chamow, Ph.D., Senior Vice President, CMC Development, leads an interactive briefing on the impact of COVID-19 on clinical biomanufacturing and supply chains.…
Chamow & Associates is pleased to announce that BioProcess International has awarded our article, “Capture of CH1-Containing Bispecific Antibodies: Evaluating an Alternative to Protein A,” by Steven M. Chamow, Angela Linderholm, Katherine…
Join us for a 30-minute fast-track digital brief on the Impact of COVID-19 on Clinical Biomanufacturing and Supply Chains. About this Event Since the onset of the COVID-19 pandemic, scientists…